New York Magazine looks at how weight loss drugs have given college women an easier, more effective way to chase thinness than past generations had.
Recap by typeshit. Video by New York Magazine on TikTok.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Investors wanted a near-term plan but got 2030 targets instead, while CagriSema missed against Zepbound and Morgan Stanley downgraded the stock over the semaglutide patent cliff.
Olhar Digital reports a Chinese approval for Wegovy, Novo Nordisk's semaglutide shot for weight loss. Few details beyond the headline were given.
Loading…